IDEXX Laboratories, Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue of IDEXX Laboratories, Inc. on 31/03/2021 amounted to 777 707 000 $. The dynamics of IDEXX Laboratories, Inc. net revenue grew by 56 769 000 $ compared to the previous report. Net income, revenue and dynamics - the main financial indicators of IDEXX Laboratories, Inc.. Graph of finance company IDEXX Laboratories, Inc.. The financial schedule of IDEXX Laboratories, Inc. consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The financial report chart on our website displays information by dates from 30/06/2017 to 31/03/2021.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
777 707 000 $
+35.01 % ↑
204 257 000 $
+98.92 % ↑
31/12/2020
720 938 000 $
+19.08 % ↑
174 790 000 $
+93.15 % ↑
30/09/2020
721 789 000 $
+19.24 % ↑
146 219 000 $
+34.35 % ↑
30/06/2020
637 592 000 $
+2.82 % ↑
148 940 000 $
+18.48 % ↑
31/12/2019
605 446 000 $
-
90 496 000 $
-
30/09/2019
605 303 000 $
-
108 837 000 $
-
30/06/2019
620 103 000 $
-
125 706 000 $
-
31/03/2019
576 056 000 $
-
102 681 000 $
-
31/12/2018
549 386 000 $
-
85 638 000 $
-
30/09/2018
545 448 000 $
-
93 251 000 $
-
30/06/2018
580 752 000 $
-
108 691 000 $
-
31/03/2018
537 656 000 $
-
89 451 000 $
-
31/12/2017
506 121 000 $
-
38 257 000 $
-
30/09/2017
491 976 000 $
-
70 511 000 $
-
30/06/2017
508 940 000 $
-
85 357 000 $
-
Show:
to
IDEXX Laboratories, Inc. financial report charts
The latest dates of IDEXX Laboratories, Inc. financial statements available online: 30/06/2017, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of IDEXX Laboratories, Inc. for today is 31/03/2021. Gross profit IDEXX Laboratories, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit IDEXX Laboratories, Inc. is 470 782 000 $
IDEXX Laboratories, Inc. quarterly report dates
Cost of revenue IDEXX Laboratories, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue IDEXX Laboratories, Inc. is 306 925 000 $ Total revenue IDEXX Laboratories, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue IDEXX Laboratories, Inc. is 777 707 000 $ Operating income IDEXX Laboratories, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income IDEXX Laboratories, Inc. is 247 622 000 $
Net income IDEXX Laboratories, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income IDEXX Laboratories, Inc. is 204 257 000 $ Current assets IDEXX Laboratories, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets IDEXX Laboratories, Inc. is 1 097 798 000 $ Total assets IDEXX Laboratories, Inc. refers to the total amount of assets owned by a person or entity. Total assets IDEXX Laboratories, Inc. is 2 327 385 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
470 782 000 $
409 502 000 $
422 606 000 $
379 342 000 $
331 149 000 $
344 950 000 $
357 853 000 $
331 597 000 $
300 361 000 $
305 643 000 $
332 439 000 $
303 099 000 $
272 474 000 $
274 002 000 $
292 715 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
306 925 000 $
311 436 000 $
299 183 000 $
258 250 000 $
274 297 000 $
260 353 000 $
262 250 000 $
244 459 000 $
249 025 000 $
239 805 000 $
248 313 000 $
234 557 000 $
233 647 000 $
217 974 000 $
216 225 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
777 707 000 $
720 938 000 $
721 789 000 $
637 592 000 $
605 446 000 $
605 303 000 $
620 103 000 $
576 056 000 $
549 386 000 $
545 448 000 $
580 752 000 $
537 656 000 $
506 121 000 $
491 976 000 $
508 940 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
605 446 000 $
605 303 000 $
620 103 000 $
576 056 000 $
549 386 000 $
545 448 000 $
580 752 000 $
537 656 000 $
506 121 000 $
491 976 000 $
508 940 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
247 622 000 $
185 095 000 $
171 856 000 $
193 248 000 $
115 631 000 $
139 802 000 $
164 275 000 $
133 138 000 $
115 347 000 $
117 350 000 $
145 594 000 $
113 044 000 $
97 808 000 $
100 413 000 $
122 564 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
204 257 000 $
174 790 000 $
146 219 000 $
148 940 000 $
90 496 000 $
108 837 000 $
125 706 000 $
102 681 000 $
85 638 000 $
93 251 000 $
108 691 000 $
89 451 000 $
38 257 000 $
70 511 000 $
85 357 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
37 579 000 $
38 777 000 $
37 517 000 $
31 645 000 $
35 160 000 $
34 260 000 $
32 259 000 $
31 514 000 $
30 138 000 $
29 192 000 $
29 510 000 $
29 023 000 $
28 809 000 $
27 585 000 $
26 998 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
530 085 000 $
535 843 000 $
549 933 000 $
444 344 000 $
489 815 000 $
465 501 000 $
455 828 000 $
442 918 000 $
185 014 000 $
188 293 000 $
186 845 000 $
190 055 000 $
174 666 000 $
173 589 000 $
170 151 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
1 097 798 000 $
1 062 738 000 $
868 679 000 $
779 612 000 $
679 639 000 $
703 382 000 $
712 298 000 $
697 646 000 $
654 172 000 $
704 197 000 $
739 832 000 $
701 707 000 $
971 985 000 $
942 722 000 $
918 658 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
2 327 385 000 $
2 294 561 000 $
2 047 407 000 $
1 960 713 000 $
1 832 475 000 $
1 751 481 000 $
1 724 237 000 $
1 680 968 000 $
1 537 349 000 $
1 544 530 000 $
1 520 685 000 $
1 469 492 000 $
1 713 416 000 $
1 669 334 000 $
1 637 137 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
351 163 000 $
383 928 000 $
175 587 000 $
105 293 000 $
90 326 000 $
103 996 000 $
110 845 000 $
116 616 000 $
123 794 000 $
146 877 000 $
174 559 000 $
159 229 000 $
187 675 000 $
169 019 000 $
165 975 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
725 337 000 $
626 627 000 $
618 909 000 $
689 619 000 $
398 937 000 $
414 500 000 $
437 000 000 $
407 500 000 $
655 000 000 $
686 250 000 $
704 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
123 794 000 $
146 877 000 $
174 559 000 $
159 229 000 $
471 930 000 $
454 104 000 $
422 898 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
1 654 650 000 $
1 548 759 000 $
1 552 688 000 $
1 629 098 000 $
1 000 285 000 $
1 016 916 000 $
1 040 130 000 $
1 016 505 000 $
1 261 075 000 $
1 290 399 000 $
1 304 891 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
90.30 %
88.43 %
90.05 %
96.91 %
65.07 %
65.84 %
68.40 %
69.17 %
73.60 %
77.30 %
79.71 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
702 696 000 $
632 088 000 $
440 576 000 $
272 963 000 $
177 473 000 $
202 418 000 $
171 246 000 $
51 562 000 $
-9 513 000 $
-1 604 000 $
-41 127 000 $
-49 272 000 $
-54 106 000 $
-48 622 000 $
-86 335 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
155 413 000 $
132 265 000 $
137 102 000 $
34 378 000 $
135 648 000 $
110 708 000 $
118 830 000 $
34 898 000 $
121 126 000 $
110 684 000 $
110 192 000 $
Last revenue report of IDEXX Laboratories, Inc. was 31/03/2021. According to last financial report total revenue in IDEXX Laboratories, Inc. was 777 707 000 US dollar and changed by +35.01% since last year. Net income in IDEXX Laboratories, Inc. was 204 257 000 $ in last quartal, net income changes to +98.92%.
Current cash IDEXX Laboratories, Inc. - the sum of all of the cash a company has on the date of report. Current cash IDEXX Laboratories, Inc. is 351 163 000 $
IDEXX Laboratories, Inc. stocks data
IDXX stock price
IDEXX Laboratories, Inc. stock price today, IDXX stock quote.
